ArticleAnnals of surgical oncology2025

The Value of Sentinel Node Biopsy in Patients With Higher-Risk (T3, T4) Primary Cutaneous Melanomas: Insights Provided by a Stage II Risk Calculator.

Thomas E Pennington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.